Tissue arrays confirmed that ERα-positive IDCs have higher GART protein levels than ERα-negative IDCs, and metabolomic analyses revealed that glutamine is more abundant in ERα-positive IDC cell lines and breast tumors than in ERα-negative ones. Here, ESR1 is linked to breast neoplasm.